GT
GCVRZ

Glenmede Trust’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Glenmede Trust’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-100
Closed – – 2886
2016
Q4 		$0 Hold
100
– – ﹤0.01% 2798
2016
Q3 		$0 Hold
100
– – ﹤0.01% 2829
2016
Q2 		$0 Hold
100
– – ﹤0.01% 2929
2016
Q1 		$0 Hold
100
– – ﹤0.01% 2886
2015
Q4 		$0 Hold
100
– – ﹤0.01% 2964
2015
Q3 		$0 Hold
100
– – ﹤0.01% 3030
2015
Q2 		$0 Hold
100
– – ﹤0.01% 2948
2015
Q1 		$0 Hold
100
– – ﹤0.01% 2711
2014
Q4 		$0 Sell
100
-194
-66% -$133 ﹤0.01% 2727
2014
Q3 		$0 Buy
+294
New +$143 ﹤0.01% 2593
2014
Q1 		– Sell
-300
Closed – – 2493
2013
Q4 		$0 Hold
300
– – ﹤0.01% 2458
2013
Q3 		$0 Hold
300
– – ﹤0.01% 2372
2013
Q2 		$0 Buy
+300
New +$527 ﹤0.01% 2220

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Glenmede Trust's GCVRZ Position: Q1 2017 in Review

Glenmede Trust sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2017, closing a stake of 100 shares.

Glenmede Trust first reported a position in GCVRZ in Q2 2013 and held it in 13 quarters. The position peaked at $0 in Q4 2016. 111 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2017.

  • Glenmede Trust reported no remaining Sanofi Contingent Value Rights position as of Q1 2017 after selling out during the quarter.
  • Glenmede Trust sold 100 Sanofi Contingent Value Rights shares in Q1 2017.
  • Glenmede Trust first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 13 quarters.
  • Glenmede Trust's Sanofi Contingent Value Rights position peaked at $0 in Q4 2016.
  • 111 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2017.

Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.